Donate
Home > Resources > A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD.
Back to Resources

A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHD.

All Variants,

All,

This study found that lisdexamfetamine (Vyvanse) significantly improved attention, sluggish cognitive tempo, and daily functioning in adults with ADHD, which may be relevant for families of individuals with 16p11.2 syndromes who commonly experience ADHD and attention difficulties.

Learn More

Pharmacology,

Back to Resources